Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Bioadaptives Inc (BDPT)

Bioadaptives Inc (BDPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BioAdaptives® Outlines Xcellara™ Platform Strategy: Integrating Stem Cell Supply and Direction for Targeted Wellness GlobeNewswire - Thu Jul 16, 7:30AM CDT

LAS VEGAS, July 16, 2026 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives® Inc. (OTC: BDPT) today outlined the scientific strategy behind its Xcellara™ cellular wellness platform ahead of the August 1,...

BDPT : 0.0016 (-40.74%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives® Inc. Announces XcellaraHeart™, a Cardiovascular Wellness Formula Built on Xcellara’s Human-Clinical Data Demonstrating a 268.8% Increase in Circulating Stem/Progenitor-Type Cells GlobeNewswire - Wed Jul 15, 7:30AM CDT

LAS VEGAS, July 15, 2026 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives® Inc. (OTC: BDPT), developer of the Xcellara™ line of stem cell mobilization supplements, today announced the upcoming commercial...

BDPT : 0.0016 (-40.74%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity GlobeNewswire - Thu Jun 25, 1:48PM CDT

LAS VEGAS, June 25, 2026 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives, Inc. (OTC: BDPT),  the parent company of MyndSystem™, today announced that its nighttime repair formula, MyndRenew™, has received...

BDPT : 0.0016 (-40.74%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery GlobeNewswire - Wed May 20, 3:15PM CDT

LAS VEGAS, May 20, 2026 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT) , a science-driven health and wellness company, today announced the official launch of MyndSystem™, a comprehensive...

BDPT : 0.0016 (-40.74%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle GlobeNewswire - Wed May 6, 7:54AM CDT

LAS VEGAS, May 06, 2026 (GLOBE NEWSWIRE) -- via IBN — More than 1 in 3 American adults report insufficient sleep — a deficit that research increasingly links to measurable declines in next-day cognitive...

BDPT : 0.0016 (-40.74%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night GlobeNewswire - Tue Apr 28, 9:00AM CDT

LAS VEGAS, April 28, 2026 (GLOBE NEWSWIRE) -- via IBN — BioAdaptives, Inc. (OTC: BDPT) today announced the official launch of MyndSystem™ and website. MyndSystem™ was originally developed...

BDPT : 0.0016 (-40.74%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing GlobeNewswire - Tue Oct 7, 2025

LAS VEGAS, Oct. 07, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT) today announced the commercial availability of MyndMed™ , a next-generation cognitive-support dietary supplement...

BDPT : 0.0016 (-40.74%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives’ MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety GlobeNewswire - Wed Aug 20, 2025

LAS VEGAS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives, Inc. (OTCMKTS: BDPT), a leader in natural health and performance supplements, today announced that its flagship nootropic formula,...

BDPT : 0.0016 (-40.74%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience GlobeNewswire - Wed Jul 16, 2025

LAS VEGAS, July 16, 2025 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC: BDPT), an innovator in evidence-based wellness solutions, today announced the upcoming national release of NeuroRush™ , a next-generation...

BDPT : 0.0016 (-40.74%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives Announces National Launch of Pawpa™ Regen GlobeNewswire - Tue Jun 24, 2025

BDPT : 0.0016 (-40.74%)
BDPTD : 0.1089 (-1.00%)

Barchart Exclusives

Alphabet Is Up 94% and Meta Is Down 5%. Barchart Data Helps Pick the Best AI Dividend Stock to Buy Now. Barchart - 1 hour ago
Alphabet’s broader ecosystem gives it the long-term edge, while Meta offers faster growth, a lower valuation and a higher yield. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.